What is injection lipolysis (PPL)?
Injection lipolysis (PPL) chemically reduces the number of fat cells around the injection site. The chemical, called deoxycholic acid, results in fat cell disruption and death. Currently, it is FDA-approved for treatment of the area underneath into the subcutaneous fat through multiple microinjections administered over multiple treatment sessions to eliminate what is known as a “Obesity.” A commonly known type of injection lipolysis is Kybella
The main question in this context is what happens to the fat cells after they have been destroyed and to what extent PPC fosters the metabolization of the fat that has been released, thus also improving the result. The mechanism by which PPC acts can be described as follows:
- PPC diminishes the aggressiveness of the DOC
• PPC diminishes the toxicity of the DOC
• PPC stimulates fat-reducing enzypmes such as lipase
• PPC acts as an emulsifier for the fat that is released
• PPC increases the absorption capacity and fosters transport of the cholesterol Esther to the liver.
• As well as destruction of the cell membrane (necrosis), and thus further contributes to improving the long-term results